Showing results (21-30 of 51) with videos related to
Sort By:
Pageof 6
Journal of Cancer Research and Clinical Oncology|October 30, 2017
Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trialsJulien Taieb, Fernando Rivera, Salvatore Siena, et al.British Journal of Cancer|July 18, 2018
Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trialsMarc Peeters, Timothy Price, Julien Taieb, et al.Journal of Cancer Research and Clinical Oncology|February 17, 2018
Author Correction: Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trialsJulien Taieb, Fernando Rivera, Salvatore Siena, et al.World Journal of Gastroenterology|August 13, 2005
Klatskin tumor treated by inter-disciplinary therapies including stereotactic radiotherapy: a case reportGerhild Becker, Felix Momm, Henning Schwacha, et al.International Journal of Colorectal Disease|January 27, 2006
Gastrointestinal cancer web sites: how do they address patients' concerns?Christian Weissenberger, David Müller, Jan Beranek-Chiu, et al.BMC Surgery|January 10, 2009
A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancerAndre Mihaljevic, Peter Büchler, Jan Harder, et al.Journal of Medical Virology|February 26, 2008
Transgenic mice replicating hepatitis B virus but lacking expression of the major HBsAgLeonie Halverscheid, Nina K Mannes, Robert Weth, et al.Journal of Hepatology|December 8, 2004
Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinomaMarcus Ritter, Mona Y Ali, Christian F Grimm, et al.Journal of Hepatology|August 10, 2005
Activation of dendritic cells by local ablation of hepatocellular carcinomaMona Y Ali, Christian F Grimm, Marcus Ritter, et al.Acta Oncologica (Stockholm, Sweden)|September 13, 2013
Docetaxel, oxaliplatin and capecitabine (TEX regimen) in patients with metastatic gastric or gastro-esophageal cancer: results of a multicenter phase I/II studyAlexander Stein, Dirk Arnold, Peter C Thuss-Patience, et al.Pageof 6